Transcatheter (percutaneous) Mitral Valve Market Key Opportunities, Strategic Assessment Forecast To 2022

Precision Business Insights published a research report on "Transcatheter (percutaneous) Mitral Valve Market By Product Type (Transfemoral implantation, Transapical implantation), By Distribution Channel (Hospitals, Cardiac care centers, Others) and Geography - Global/Region/Country Forecast to 2028"

For the treatment of severe aortic stenosis as well as mitral regurgitation, transcatheter heart valve implantation is a method that uses a less intrusive approach to replace the heart valve with a prosthetic valve. It is a viable alternative to invasive open-heart surgery, particularly in high-risk patients. The surgery improves patients' survival rates by reducing severe degenerative aortic stenosis. As the incidence of severe aortic stenosis and asymptomatic severe mitral regurgitation rises in the elderly, demand for transcatheter heart valve devices is predicted to rise.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/transcatheter-percutaneous-mitral-valve-market/

The rising demand for less intrusive procedures for high-risk patients, as well as the increased incidence of mitral regurgitation as well as severe aortic stenosis condition, are driving the transcatheter heart valve replacement and repair market. Transcatheter heart valve devices are also being adopted due to quicker recovery times, shorter hospital stays, good outcomes with transcatheter prosthetic valve implantation, and technological developments. However, the high prices of transcatheter heart valves, the danger involved with the surgery, and some device-related issues such as manufacturer product recalls and mispositioning after implantation stymie market growth to some extent.

On the basis of Product, the market is segregated into Mechanical Valves & Bioprosthetic Tissue (Biological) Valves). On the basis of Application, the market is classified into Mitral Valve Prolapse, Mitral Valve Stenosis, Mitral Valve Regurgitation. On the basis of End Use, the market is divided into Ambulatory Surgical Centers, Hospitals, and Diagnostic Centers.

Owing to the rising prevalence of heart valve problems in the United States, the United States dominated the North American transcatheter heart valve replacement market, with a revenue share of roughly 87 percent in 2019. Every year, nearly 5 million people in the United States are diagnosed with heart valve dysfunction, according to a published article. As a result, over 82,000 aortic valve replacement (AVR) surgeries are performed in the United States each year. As a result, demand for transcatheter heart valves in the United States has remained stable. The Centers for Medicare & Mediclaim's favourable reimbursement scenario for transcatheter heart valve replacement treatments are also increasing the number of persons getting valve replacement. Due to improving healthcare infrastructure and rising frequency of aortic stenosis in the senior population, Germany's transcatheter heart valve replacement market value was over USD 386 million in 2019.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=23400

There are several industry players working in the Transcatheter (percutaneous) Mitral Valve Market, which include Boston Scientific Corporation (U.S) Abbott Laboratories (U.S) Edwards Lifesciences Corporation Micro Interventional Devices (U.S) Neochord Inc. (U.S) Medtronic, Inc. (U.S) Jude Medical, Inc. (U.S) JenaValve Technology (U.S) Livanova Plc, (U.K) Colibri Heart Valve, Llc. (U.S) Neovasc (Canada)

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.